These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15364827)

  • 1. Rhythm control and increased risk of noncardiovascular death in the Atrial Fibrillation Follow-up Investigation of Rhythm Management trial.
    Boriani G; Biffi M; Mattioli S
    Circulation; 2004 Sep; 110(11):e307-8; author reply e307-8. PubMed ID: 15364827
    [No Abstract]   [Full Text] [Related]  

  • 2. Is rate control better than rhythm control for atrial fibrillation in older high-risk patients?
    Saseen JJ
    J Fam Pract; 2003 Mar; 52(3):192, 194. PubMed ID: 12620170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Steinberg JS; Sadaniantz A; Kron J; Krahn A; Denny DM; Daubert J; Campbell WB; Havranek E; Murray K; Olshansky B; O'Neill G; Sami M; Schmidt S; Storm R; Zabalgoitia M; Miller J; Chandler M; Nasco EM; Greene HL
    Circulation; 2004 Apr; 109(16):1973-80. PubMed ID: 15051639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study.
    Olshansky B; Sami M; Rubin A; Kostis J; Shorofsky S; Slee A; Greene HL;
    Am J Cardiol; 2005 Feb; 95(3):404-5. PubMed ID: 15670555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate control vs rhythm control strategies in atrial fibrillation.
    Wyse DG
    Prog Cardiovasc Dis; 2005; 48(2):125-38. PubMed ID: 16253652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin versus placebo for conversion of acute atrial fibrillation to sinus rhythm.
    Veloso HH; de Paola AA
    Am J Cardiol; 1999 Apr; 83(8):1300-1. PubMed ID: 10215309
    [No Abstract]   [Full Text] [Related]  

  • 10. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G; Prystowsky EN
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):514-21. PubMed ID: 16186849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate control versus rhythm control.
    Vidaillet H; Greenlee RT
    Curr Opin Cardiol; 2005 Jan; 20(1):15-20. PubMed ID: 15596954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of rate versus rhythm in rheumatic atrial fibrillation.
    Juneja R; Gulati G
    Indian Heart J; 2004; 56(4):356-7; author reply 357. PubMed ID: 15586750
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of drugs in pursuit of a rhythm control strategy.
    Kowey PR; Stoenescu ML
    Prog Cardiovasc Dis; 2005; 48(2):139-45. PubMed ID: 16253653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate versus rhythm control in atrial fibrillation: no one-size-fits-all.
    McClanahan AL; Curtis AB
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):891-3. PubMed ID: 20602548
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug therapy for atrial fibrillation.
    Musco S; Conway EL; Kowey PR
    Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic methods of rate control in atrial fibrillation].
    Kargul W
    Kardiol Pol; 2004 May; 60(5):529-30. PubMed ID: 15247973
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).
    Hohnloser SH; Kuck KH
    Eur Heart J; 2001 May; 22(10):801-2. PubMed ID: 11350085
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of drugs in pursuit of rate control strategy.
    Samii SM; Hynes BJ; Khan M; Wolbrette DL; Luck JC; Naccarelli GV
    Prog Cardiovasc Dis; 2005; 48(2):146-52. PubMed ID: 16253654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
    O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
    Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.